Nasdaq - Delayed Quote USD

Franklin Biotechnology Discovery Adv (FTDZX)

134.47 -1.85 (-1.36%)
As of 8:06 AM EDT. Market Open.
Loading Chart for FTDZX
DELL
  • Previous Close 136.32
  • YTD Return 11.55%
  • Expense Ratio 1.07%
  • Category Health
  • Last Cap Gain 26.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 949.93M
  • Beta (5Y Monthly) 0.68
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 24.08%
  • Last Dividend 0.42
  • Inception Date Sep 15, 1997

Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

Franklin Templeton Investments

Fund Family

Health

Fund Category

949.93M

Net Assets

1997-09-15

Inception Date

Performance Overview: FTDZX

Trailing returns as of 4/25/2024. Category is Health.

YTD Return

FTDZX
11.55%
Category
7.95%
 

1-Year Return

FTDZX
31.20%
Category
30.16%
 

3-Year Return

FTDZX
0.38%
Category
16.10%
 

5-Year Return

FTDZX
7.11%
Category
15.71%
 

People Also Watch

Holdings: FTDZX

Top 10 Holdings (40.11% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 6.77%
REGN
Regeneron Pharmaceuticals, Inc. 6.30%
VRTX
Vertex Pharmaceuticals Incorporated 5.24%
ASND
Ascendis Pharma A/S 4.05%
INFXX
Institutional Fiduciary Trust Money Market Fund 3.69%
GILD
Gilead Sciences, Inc. 3.12%
BIIB
Biogen Inc. 2.94%
AZN
AstraZeneca PLC 2.83%
ITCI
Intra-Cellular Therapies, Inc. 2.59%
JAZZ
Jazz Pharmaceuticals plc 2.58%

Sector Weightings

SectorFTDZX
Healthcare   98.72%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related Mutual Fund News

Top Mutual Funds